Psychometric Properties Upper Limb Function Measures Multiple Sclerosis

NCT02339675 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 136

Last updated 2020-05-22

No results posted yet for this study

Summary

Current study will investigate de quality (psychometric properties) and clinical utility of several measures of upper limb function, according to disability level. Therefore, several aspects will be inquired:

* Was there an effect of rehabilitation
* Is the measure able to detect change over time? And thus the change exceed measurement error and is it clinically important (responsiveness)
* Does the measure assess what it claims to measure (validity)
* Is the measure able to differentiate all performances of the patients, inclusively the very good and very bad performances (floor and ceiling effects)
* Does the measure gives similar results under consistent test conditions on another testing day (reliability) Worldwide, theoretical approaches to physical therapy and rehabilitation in Multiple Sclerosis often appear significantly different. Since the present research protocol will be performed at different centers across European countries (and US sites), this multi-center study can additionally be applied for mapping the volume and content of rehabilitation, as well as the differential impact of diverse rehabilitation approaches and training volume on mobility, for several disability levels.

Some health-economic analyses will be performed to examine what the approximate cost of rehabilitation compared to effects is and what drivers of costs are (setting, equipment, staff).

Conditions

Interventions

OTHER

conventional MS rehabilitation

assessment pre and post conventional MS rehabilitation

Sponsors & Collaborators

  • Revalidatie & MS Centrum Overpelt

    collaborator OTHER
  • Charles University, Czech Republic

    collaborator OTHER
  • Danish MS Hospitals, Haslev and Ry

    collaborator OTHER
  • Fondazione Don Carlo Gnocchi Onlus

    collaborator OTHER
  • Italian Multiple Sclerosis Foundation

    collaborator OTHER
  • centrisclerosimultipla

    collaborator UNKNOWN
  • Sheba Medical Center

    collaborator OTHER_GOV
  • Haukeland University Hospital

    collaborator OTHER
  • MS Rehabilitation Center Borne Sulinowo

    collaborator UNKNOWN
  • University of Ljubljana

    collaborator OTHER
  • Eugenia Epalza Rehabilitation Center, Bilbao, Spain

    collaborator OTHER
  • Day General Hospital.

    collaborator OTHER
  • Shepherd Center, Atlanta GA

    collaborator OTHER
  • Queen's University

    collaborator OTHER
  • St. Louis University

    collaborator OTHER
  • De Mick

    collaborator UNKNOWN
  • MS center Hakadal AS

    collaborator UNKNOWN
  • Hasselt University

    lead OTHER

Principal Investigators

  • Peter Feys, prof. dr. · Hasselt University

  • Ilse Baert, dr. · Hasselt University

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-10-31
Primary Completion
2016-02-29
Completion
2016-06-30

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02339675 on ClinicalTrials.gov